N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]cyclobutanecarboxamide;N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]cyclopropanecarboxamide;N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]-2-methylpropanamide;N-[5-[4-(morpholin-4-ylmethyl)phenyl]imidazo[1,2-a]pyridin-2-yl]cyclopropanecarboxamide

C89H100N16O11S3 — CID 159514568

IUPACN-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]cyclobutanecarboxamide;N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]cyclopropanecarboxamide;N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]-2-methylpropanamide;N-[5-[4-(morpholin-4-ylmethyl)phenyl]imidazo[1,2-a]pyridin-2-yl]cyclopropanecarboxamide
SMILESCC(C)C(=O)Nc1cn2c(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)cccc2n1.O=C(Nc1cn2c(-c3ccc(CN4CCOCC4)cc3)cccc2n1)C1CC1.O=C(Nc1cn2c(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)cccc2n1)C1CC1.O=C(Nc1cn2c(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)cccc2n1)C1CCC1
InChIInChI=1S/C23H26N4O3S.C22H24N4O3S.C22H26N4O3S.C22H24N4O2/c28-23(19-3-1-4-19)25-21-16-27-20(5-2-6-22(27)24-21)18-9-7-17(8-10-18)15-26-11-13-31(29,30)14-12-26;27-22(18-8-9-18)24-20-15-26-19(2-1-3-21(26)23-20)17-6-4-16(5-7-17)14-25-10-12-30(28,29)13-11-25;1-16(2)22(27)24-20-15-26-19(4-3-5-21(26)23-20)18-8-6-17(7-9-18)14-25-10-12-30(28,29)13-11-25;27-22(18-8-9-18)24-20-15-26-19(2-1-3-21(26)23-20)17-6-4-16(5-7-17)14-25-10-12-28-13-11-25/h2,5-10,16,19H,1,3-4,11-15H2,(H,25,28);1-7,15,18H,8-14H2,(H,24,27);3-9,15-16H,10-14H2,1-2H3,(H,24,27);1-7,15,18H,8-14H2,(H,24,27)
InChIKeyMBAFMMXIFITYJB-UHFFFAOYSA-N
MW1666.08 g/mol
LogP11.56
Rot. Bonds20

About N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]cyclobutanecarboxamide;N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]cyclopropanecarboxamide;N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]-2-methylpropanamide;N-[5-[4-(morpholin-4-ylmethyl)phenyl]imidazo[1,2-a]pyridin-2-yl]cyclopropanecarboxamide

N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]cyclobutanecarboxamide;N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]cyclopropanecarboxamide;N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]-2-methylpropanamide;N-[5-[4-(morpholin-4-ylmethyl)phenyl]imidazo[1,2-a]pyridin-2-yl]cyclopropanecarboxamide (PubChem CID 159514568) has the molecular formula C89H100N16O11S3 and a molecular weight of 1666.08 g/mol. Its IUPAC name is N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]cyclobutanecarboxamide;N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]cyclopropanecarboxamide;N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]-2-methylpropanamide;N-[5-[4-(morpholin-4-ylmethyl)phenyl]imidazo[1,2-a]pyridin-2-yl]cyclopropanecarboxamide.

Molecular Properties

Compound NameN-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]cyclobutanecarboxamide;N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]cyclopropanecarboxamide;N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]-2-methylpropanamide;N-[5-[4-(morpholin-4-ylmethyl)phenyl]imidazo[1,2-a]pyridin-2-yl]cyclopropanecarboxamide
PubChem CID159514568
Molecular FormulaC89H100N16O11S3
Molecular Weight1666.08 g/mol
Exact Mass1664.69
IUPAC NameN-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]cyclobutanecarboxamide;N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]cyclopropanecarboxamide;N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]-2-methylpropanamide;N-[5-[4-(morpholin-4-ylmethyl)phenyl]imidazo[1,2-a]pyridin-2-yl]cyclopropanecarboxamide
SMILESCC(C)C(=O)Nc1cn2c(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)cccc2n1.O=C(Nc1cn2c(-c3ccc(CN4CCOCC4)cc3)cccc2n1)C1CC1.O=C(Nc1cn2c(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)cccc2n1)C1CC1.O=C(Nc1cn2c(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)cccc2n1)C1CCC1
InChIInChI=1S/C23H26N4O3S.C22H24N4O3S.C22H26N4O3S.C22H24N4O2/c28-23(19-3-1-4-19)25-21-16-27-20(5-2-6-22(27)24-21)18-9-7-17(8-10-18)15-26-11-13-31(29,30)14-12-26;27-22(18-8-9-18)24-20-15-26-19(2-1-3-21(26)23-20)17-6-4-16(5-7-17)14-25-10-12-30(28,29)13-11-25;1-16(2)22(27)24-20-15-26-19(4-3-5-21(26)23-20)18-8-6-17(7-9-18)14-25-10-12-30(28,29)13-11-25;27-22(18-8-9-18)24-20-15-26-19(2-1-3-21(26)23-20)17-6-4-16(5-7-17)14-25-10-12-28-13-11-25/h2,5-10,16,19H,1,3-4,11-15H2,(H,25,28);1-7,15,18H,8-14H2,(H,24,27);3-9,15-16H,10-14H2,1-2H3,(H,24,27);1-7,15,18H,8-14H2,(H,24,27)
InChIKeyMBAFMMXIFITYJB-UHFFFAOYSA-N
XLogP11.56
TPSA310.21 Ų
H-Bond Donors4
H-Bond Acceptors23
Rotatable Bonds20
Heavy Atoms119
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001666.08
LogP ≤ 511.56
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1023

Analyze N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]cyclobutanecarboxamide;N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]cyclopropanecarboxamide;N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]-2-methylpropanamide;N-[5-[4-(morpholin-4-ylmethyl)phenyl]imidazo[1,2-a]pyridin-2-yl]cyclopropanecarboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]cyclobutanecarboxamide;N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]cyclopropanecarboxamide;N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]-2-methylpropanamide;N-[5-[4-(morpholin-4-ylmethyl)phenyl]imidazo[1,2-a]pyridin-2-yl]cyclopropanecarboxamide?
The IUPAC name of N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]cyclobutanecarboxamide;N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]cyclopropanecarboxamide;N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]-2-methylpropanamide;N-[5-[4-(morpholin-4-ylmethyl)phenyl]imidazo[1,2-a]pyridin-2-yl]cyclopropanecarboxamide (CID 159514568) is N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]cyclobutanecarboxamide;N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]cyclopropanecarboxamide;N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]-2-methylpropanamide;N-[5-[4-(morpholin-4-ylmethyl)phenyl]imidazo[1,2-a]pyridin-2-yl]cyclopropanecarboxamide.
What is the SMILES notation for N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]cyclobutanecarboxamide;N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]cyclopropanecarboxamide;N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]-2-methylpropanamide;N-[5-[4-(morpholin-4-ylmethyl)phenyl]imidazo[1,2-a]pyridin-2-yl]cyclopropanecarboxamide?
The canonical SMILES for N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]cyclobutanecarboxamide;N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]cyclopropanecarboxamide;N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]-2-methylpropanamide;N-[5-[4-(morpholin-4-ylmethyl)phenyl]imidazo[1,2-a]pyridin-2-yl]cyclopropanecarboxamide is CC(C)C(=O)Nc1cn2c(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)cccc2n1.O=C(Nc1cn2c(-c3ccc(CN4CCOCC4)cc3)cccc2n1)C1CC1.O=C(Nc1cn2c(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)cccc2n1)C1CC1.O=C(Nc1cn2c(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)cccc2n1)C1CCC1.
What is the InChIKey of N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]cyclobutanecarboxamide;N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]cyclopropanecarboxamide;N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]-2-methylpropanamide;N-[5-[4-(morpholin-4-ylmethyl)phenyl]imidazo[1,2-a]pyridin-2-yl]cyclopropanecarboxamide?
The InChIKey is MBAFMMXIFITYJB-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H26N4O3S.C22H24N4O3S.C22H26N4O3S.C22H24N4O2/c28-23(19-3-1-4-19)25-21-16-27-20(5-2-6-22(27)24-21)18-9-7-17(8-10-18)15-26-11-13-31(29,30)14-12-26;27-22(18-8-9-18)24-20-15-26-19(2-1-3-21(26)23-20)17-6-4-16(5-7-17)14-25-10-12-30(28,29)13-11-25;1-16(2)22(27)24-20-15-26-19(4-3-5-21(26)23-20)18-8-6-17(7-9-18)14-25-10-12-30(28,29)13-11-25;27-22(18-8-9-18)24-20-15-26-19(2-1-3-21(26)23-20)17-6-4-16(5-7-17)14-25-10-12-28-13-11-25/h2,5-10,16,19H,1,3-4,11-15H2,(H,25,28);1-7,15,18H,8-14H2,(H,24,27);3-9,15-16H,10-14H2,1-2H3,(H,24,27);1-7,15,18H,8-14H2,(H,24,27).
What are the key properties of N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]cyclobutanecarboxamide;N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]cyclopropanecarboxamide;N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]-2-methylpropanamide;N-[5-[4-(morpholin-4-ylmethyl)phenyl]imidazo[1,2-a]pyridin-2-yl]cyclopropanecarboxamide?
N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]cyclobutanecarboxamide;N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]cyclopropanecarboxamide;N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]-2-methylpropanamide;N-[5-[4-(morpholin-4-ylmethyl)phenyl]imidazo[1,2-a]pyridin-2-yl]cyclopropanecarboxamide has a molecular weight of 1666.08 g/mol, XLogP of 11.56, 20 rotatable bonds, 4 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]cyclobutanecarboxamide;N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]cyclopropanecarboxamide;N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]imidazo[1,2-a]pyridin-2-yl]-2-methylpropanamide;N-[5-[4-(morpholin-4-ylmethyl)phenyl]imidazo[1,2-a]pyridin-2-yl]cyclopropanecarboxamide is sourced from PubChem (CID 159514568), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).